JP Morgan Chase
GMED icon

JP Morgan Chase’s Globus Medical GMED Stock Holding History

JP Morgan Chase’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231M Buy
2,743,850
+148,542
+6% +$12.6M 0.01% 705
2026
Q1 		$217M Sell
2,595,308
-503,465
-16% -$45.2M 0.01% 663
2025
Q4 		$271M Sell
3,098,773
-583,184
-16% -$44.3M 0.02% 574
2025
Q3 		$211M Buy
3,681,957
+341,201
+10% +$19.6M 0.01% 675
2025
Q2 		$197M Buy
3,340,756
+712,374
+27% +$46M 0.01% 688
2025
Q1 		$192M Sell
2,628,382
-175,948
-6% -$14.5M 0.01% 688
2024
Q4 		$232M Buy
2,804,330
+199,556
+8% +$15.7M 0.02% 613
2024
Q3 		$186M Sell
2,604,774
-31,077
-1% -$2.19M 0.01% 711
2024
Q2 		$181M Buy
2,635,851
+523,748
+25% +$31.3M 0.01% 693
2024
Q1 		$113M Buy
2,112,103
+97,472
+5% +$5.24M 0.01% 884
2023
Q4 		$107M Sell
2,014,631
-117,237
-5% -$5.71M 0.01% 846
2023
Q3 		$106M Buy
2,131,868
+231,773
+12% +$13M 0.01% 788
2023
Q2 		$113M Buy
1,900,095
+62,670
+3% +$3.57M 0.01% 767
2023
Q1 		$104M Buy
1,837,425
+498,592
+37% +$32M 0.01% 778
2022
Q4 		$99.4M Sell
1,338,833
-1,279
-0.1% -$87.1K 0.01% 771
2022
Q3 		$79.8M Buy
1,340,112
+1,087,189
+430% +$65.5M 0.01% 814
2022
Q2 		$14.2M Buy
252,923
+43,110
+21% +$2.83M ﹤0.01% 1895
2022
Q1 		$15.5M Sell
209,813
-14,640
-7% -$1.02M ﹤0.01% 1982
2021
Q4 		$16.2M Buy
224,453
+33,225
+17% +$2.41M ﹤0.01% 1997
2021
Q3 		$14.7M Buy
191,228
+13,336
+7% +$1.07M ﹤0.01% 2028
2021
Q2 		$13.8M Buy
177,892
+17,530
+11% +$1.25M ﹤0.01% 2150
2021
Q1 		$9.89M Buy
160,362
+1,719
+1% +$109K ﹤0.01% 2368
2020
Q4 		$10.3M Buy
158,643
+52,636
+50% +$3.03M ﹤0.01% 2189
2020
Q3 		$5.18M Sell
106,007
-9,173
-8% -$473K ﹤0.01% 2531
2020
Q2 		$5.5M Sell
115,180
-434,377
-79% -$21M ﹤0.01% 2389
2020
Q1 		$23.4M Buy
549,557
+222,581
+68% +$11M 0.01% 1153
2019
Q4 		$19.3M Buy
326,976
+81,750
+33% +$4.44M ﹤0.01% 1626
2019
Q3 		$12.5M Buy
245,226
+54,090
+28% +$2.58M ﹤0.01% 1953
2019
Q2 		$8.15M Buy
191,136
+39,582
+26% +$1.72M ﹤0.01% 2265
2019
Q1 		$7.49M Sell
151,554
-244,621
-62% -$11.1M ﹤0.01% 2275
2018
Q4 		$17.1M Buy
396,175
+206,284
+109% +$10.3M ﹤0.01% 1593
2018
Q3 		$10.8M Sell
189,891
-108,043
-36% -$5.69M ﹤0.01% 2142
2018
Q2 		$15M Buy
297,934
+150,712
+102% +$7.86M ﹤0.01% 1819
2018
Q1 		$7.33M Buy
147,222
+79,792
+118% +$3.75M ﹤0.01% 2256
2017
Q4 		$2.77M Buy
67,430
+65,896
+4,296% +$2.31M ﹤0.01% 3118
2017
Q3 		$46K Buy
1,534
+382
+33% +$11.7K ﹤0.01% 4490
2017
Q2 		$38K Buy
1,152
+164
+17% +$5.15K ﹤0.01% 4403
2017
Q1 		$29K Buy
988
+111
+13% +$3.03K ﹤0.01% 4651
2016
Q4 		$22K Sell
877
-2,823
-76% -$64.2K ﹤0.01% 4690
2016
Q3 		$84K Sell
3,700
-4,634
-56% -$109K ﹤0.01% 3903
2016
Q2 		$198K Buy
8,334
+8,128
+3,946% +$195K ﹤0.01% 3720
2016
Q1 		$5K Buy
206
+12
+6% +$293 ﹤0.01% 4366
2015
Q4 		$5K Buy
+194
New +$4.87K ﹤0.01% 4337
2015
Q3 		– Sell
-156,574
Closed -$4.02M – 3975
2015
Q2 		$4.02M Sell
156,574
-19,468
-11% -$493K ﹤0.01% 2528
2015
Q1 		$4.44M Sell
176,042
-193,121
-52% -$4.7M ﹤0.01% 2430
2014
Q4 		$8.78M Buy
369,163
+202,345
+121% +$4.48M ﹤0.01% 2042
2014
Q3 		$3.28M Buy
+166,818
New +$3.43M ﹤0.01% 2622
2013
Q4 		– Sell
-18,653
Closed -$326K – 4146
2013
Q3 		$326K Buy
+18,653
New +$323K ﹤0.01% 3836

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

JP Morgan Chase's GMED Position: Q2 2026 in Review

JP Morgan Chase increased its Globus Medical (GMED) stake by 5.7% in Q2 2026, buying an estimated $12.6M and bringing the position to 2,743,850 shares worth $231M. The position accounts for 0.01% of the portfolio, ranked #705.

JP Morgan Chase first reported a position in GMED in Q3 2013 and has held it in 48 quarters since. The position peaked at $271M in Q4 2025. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • JP Morgan Chase held 2,743,850 shares of Globus Medical worth $231M as of Q2 2026.
  • JP Morgan Chase bought 148,542 Globus Medical shares in Q2 2026, an estimated $12.6M.
  • Globus Medical made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #705 holding.
  • JP Morgan Chase first reported a position in Globus Medical in Q3 2013 and has held it in 48 quarters since.
  • JP Morgan Chase's Globus Medical position peaked at $271M in Q4 2025.
  • 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.